Found: 5
Select item for more details and to access through your institution.
Alpha-synuclein from patient Lewy bodies exhibits distinct pathological activity that can be propagated in vitro.
- Published in:
- Acta Neuropathologica Communications, 2021, v. 9, n. 1, p. 1, doi. 10.1186/s40478-021-01288-2
- By:
- Publication type:
- Article
α-Synuclein aggregates amplified from patient-derived Lewy bodies recapitulate Lewy body diseases in mice.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-42705-5
- By:
- Publication type:
- Article
Synthetic Proteins and Peptides for the Direct Interrogation of α-Synuclein Posttranslational Modifications.
- Published in:
- Biomolecules (2218-273X), 2015, v. 5, n. 3, p. 1210, doi. 10.3390/biom5031210
- By:
- Publication type:
- Article
O-GlcNAc Modification Prevents Peptide-Dependent Acceleration of α-Synuclein Aggregation.
- Published in:
- ChemBioChem, 2012, v. 13, n. 18, p. 2665, doi. 10.1002/cbic.201200478
- By:
- Publication type:
- Article
O-GlcNAc modification blocks the aggregation and toxicity of the protein α-synuclein associated with Parkinson's disease.
- Published in:
- Nature Chemistry, 2015, v. 7, n. 11, p. 913, doi. 10.1038/nchem.2361
- By:
- Publication type:
- Article